HOOKIPA Pharma Inc.

HOOKSEC EDGAR

Pharmaceutical Preparations(DE)CIK: 1760542

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue from Contract with Customer, Excluding Assessed Tax	$14.2M	$18.4M	$19.6M	$11.9M	$7.6M
Research and Development Expense	$68.6M	$82.9M	$54.8M	$46.3M	$22.0M
Operating Expenses	—	—	—	—	$12.9M
Operating Income (Loss)	-$73.2M	-$81.7M	-$53.3M	-$51.1M	-$21.2M
Interest Expense	—	$898.0K	$786.0K	$877.0K	$778.0K
Nonoperating Income (Expense)	$8.5M	$6.0M	$9.2M	$8.0M	$5.0M
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	-$64.7M	-$75.7M	-$44.1M

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Assets	$161.3M	$170.5M	$126.0M	$187.8M	$143.7M
Assets, Current	$147.1M	$147.2M	$102.1M	$171.5M	$128.0M
Cash and Cash Equivalents, at Carrying Value	$117.1M	$112.5M	$65.9M	$142.7M	$113.2M
Accounts Receivable, after Allowance for Credit Loss, Current	$511.0K	$6.5M	$6.9M	$5.5M	$1.5M
Liabilities	$71.5M	$67.9M	$36.5M	$31.7M	$25.8M
Liabilities, Current	$42.0M	$35.6M	$27.7M	$21.1M	$14.8M
Long-term Debt	—	$1.2M	$2.9M	$6.1M

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Net Cash Provided by (Used in) Operating Activities	-$20.0M	-$66.0M	-$39.3M	-$41.7M	-$15.0M
Net Cash Provided by (Used in) Investing Activities	-$5.0M	-$12.6M	-$2.4M	-$2.0M	-$2.1M
Net Cash Provided by (Used in) Financing Activities	$72.3M	-$235.0K	$73.4M	$109.8M	$6.9M
Payments to Acquire Property, Plant, and Equipment	$5.0M	$12.6M	$2.4M	$2.0M	$2.1M

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)